Belgian Registry on Coronary Function Testing

Last updated: October 12, 2023
Sponsor: University Hospital, Antwerp
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Coronary Function Test

Clinical Study ID

NCT06089031
2021-0522
  • Ages > 18
  • All Genders

Study Summary

The goal of this prospective, multicenter registy is to describe the 'real-world' use of coronary function tests, which may consist of bolus thermodilution measurements of coronary microvascular function and/or invasive vasoreactivity tests with acetylcholine, in the current Belgian routine practice. The main questions it aims to answer are:

  • how frequent are coronary function tests performed

  • what is the indication for coronary function tests

  • what is the frequency of coronary microvascular dysfunction

  • what is the frequency of coronary artery vasospasm

From each participant, data will be collected from their medical files concerning cardiovascular risk factors, relevant past medical history, non-invasive tests, procedural data, and follow-up data from routine in-patient visits. Their are no specific study visits. Optionally, patients will be asked to fill in questionnaires about anginal symptoms and quality of life.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient scheduled for coronary function test, comprising of intracoronary bolusthermodilution measurements of microvascular function, and/or intracoronaryvasoreactivity tests with acetylcholine.
  • Subject understands the study requirements and provides written informed consent.

Exclusion

Exclusion Criteria:

  • Subject is participating in another investigational clinical trial that may causenon-compliance with the protocol or confound data interpretation.
  • Subject intends to participate in another investigational clinical trial that maycause non-compliance with the protocol or confound data interpretation.
  • Documented or suspected pregnancy.
  • Inability to provide written informed consent.

Study Design

Total Participants: 650
Treatment Group(s): 1
Primary Treatment: Coronary Function Test
Phase:
Study Start date:
October 18, 2021
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • AZ Monica

    Deurne, Antwerp 2100
    Belgium

    Active - Recruiting

  • AZ Sint-Maarten

    Mechelen, Antwerp 2800
    Belgium

    Active - Recruiting

  • Jessa Hasselt

    Hasselt, Limburg 3500
    Belgium

    Active - Recruiting

  • OLV Aalst

    Aalst, 9300
    Belgium

    Active - Recruiting

  • University Hospital Antwerp

    Antwerp, 2650
    Belgium

    Active - Recruiting

  • Ziekenhuis aan de Stroom (ZAS)

    Antwerp, 2020
    Belgium

    Active - Recruiting

  • AZ Sint-Jan Brugge

    Brugge, 8000
    Belgium

    Active - Recruiting

  • AZ Jan Yperman

    Ieper, 8900
    Belgium

    Active - Recruiting

  • AZ Groeninge

    Kortrijk, 8500
    Belgium

    Active - Recruiting

  • UZ Leuven

    Leuven, 3000
    Belgium

    Active - Recruiting

  • CHC Montlégia Liège

    Liège, 4000
    Belgium

    Active - Recruiting

  • CHR Citadelle Liège

    Liège,
    Belgium

    Active - Recruiting

  • AZ Delta

    Roeselare, 8800
    Belgium

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.